Title: Animal Drug Availability Act (ADAA) of 1996
1Animal Drug Availability Act (ADAA) of 1996
- Legislative History of ADAA and Import Tolerances
- Jarilyn Dupont
- Senior Legislative Counsel
- Food and Drug Administration
- January 22, 2002
2ADAA Public Law 104-250Signed into Law 10/09/96
- ADAA was designed to increase the number of
animal drugs on the market, without compromising
FDAs mission to promote and protect the public
health. - Culmination of collaboration between FDA, a
coalition of animal industry groups, and
manufacturers of animal drugs. Passed with strong
bipartisan support.
3ADAA Impact on Animal Drug Review
- Section 2 Evidence of Effectiveness Injects
flexibility in the review and approval process by
amending the current definition of substantial
evidence - Section 3 Limitation on Residues Supports
flexible labeling to permit a range of
acceptable or recommended doses to appear on the
label
4ADAA Impact on Animal Drug Review
- Section 4 Import Tolerances
- Permits the establishment of tolerance levels for
drug residues in imported food products of animal
origin - Section 5 Veterinary Feed Directive Creates a
new category of drug approvals
5ADAA Impact on Animal Drug Review
- Section 6 Feed Mill Licenses
- Establishes a new system for licensing feed mills
6ADAA Path to Passage
- Senate
- 05/09/95 S. 773 Introduced
- 12/13/95 S.1477 Introduced
- 02/21/96 Hearings on S. 1477
- 03/28/96 S. 1477 Passed Committee
- 06/20/96 S. 1477 Reported to Senate
- 09/24/96 Committee Mark-up of S. 773 - Passes
Senate (identical to H.R. 2508) - 9/28/96 Presented to
- President
- 10/09/96 Signed into Law
- House
- 10/19/95 H.R. 2508 Introduced
- 03/29/96 H.R. 3200 Introduced
- 05/01/96 Hearings on H.R. 3200
- 09/19/96 Committee Mark-up of H.R. 3200
- 09/24/96 H.R. 2508 Passes House (identical to
S.773) - 09/28/96 Presented to President
- 10/09/96 Signed into Law
7ADAA Chronology
- S. 773, ADAA, introduced 05/09/95 by
- Senator Nancy Kassebaum 19 cosponsors -
referred to Senate Labor Committee - H.R. 2508, ADAA, introduced 10/19/95 by Rep.
Wayne Allard 71 cosponsors - referred to House
Commerce Committee
8ADAA Chronology
- S. 773 and H.R. 2508, nearly identical. Neither
contained an import tolerance provision - In floor remarks, sponsors stated the reason for
the bill was concern that the animal drug
approval process had become cumbersome and
unpredictable and increasingly prolonged and
complicated.
9ADAA Chronology
- No further official action on S. 773 or H.R. 2508
until 1996 - 12/13/95 S. 1477, The FDA Performance and
Accountability Act introduced by Senator Nancy
Kassebaum 4 cosponsors - Comprehensive Reform bill, contained animal drug
reform provisions
10ADAA Chronology
- 01/1996 Reinventing Food Regulations, National
Performance Review - Includes proposal to
enable FDA to focus its reviews on the safety
of the drug residue in the imported food
product, among other animal drug initiatives
11ADAA Chronology
- 02/21/96 Senate Labor Committee hearings on S.
1477 - Dr. Kessler testified - 03/28/96 S. 1477 Passed Committee
- 03/29/96 H.R. 3200, Food Amendments and the
Animal Drug Availability Act of 1996 introduced
by Rep. Scott Klug.
12ADAA Chronology
- H.R. 3200 was 1 of 3 FDA Reform bills.
- Title II of H.R. 3200 - ADAA (Evidence of
Effectiveness and Limitation on Residues verbatim
from H.R. 2508 - also picks up provisions from
the REGO initiative)
13ADAA Chronology
- 05/01-02/96 House Commerce Subcommittee Hearings
on the 3 FDA Reform Bills - Dr. Kessler testified - 05/1996 Reinventing the Regulation of Animal
Drugs National Performance Review
14ADAA Chronology
- 05/29/96 One Hour Special Order in House on 3
FDA Reform bills - 06/20/96 S. 1477 Reported to Senate
- Between 06/96 - 09/96 - Committees, FDA and
Industry Coalition working on bills
15ADAA Chronology
- 09/19/96 Committee Mark-Up of H.R. 2508
Discharged, included Section 4, Import Tolerance - 09/24/96 H.R. 2508 Reported and Passed the House
by Voice Vote - (now identical to S.773) -
16ADAA Chronology
- 09/24/96 Committee Mark-Up of S. 773 Discharged,
included Section 4, Import Tolerance - 09/24/96 S. 773 Passed Senate by Unanimous
Consent (now identical to H.R. 2508)
17ADAA Chronology
- 09/28/96 Presented to the President
- 10/09/96 Signed Became Public Law
18Section 4. Import Tolerance
- Section 4. Import Tolerances.
- Section 512(a) (21 U.S.C. 360b(a)) is amended
by adding the following new paragraph at the end - '(6) For purposes of section 402(a)(2)(D), a
use or intended use of a new animal drug shall
not be deemed unsafe under this section if the
Secretary establishes a tolerance for such drug
and any edible portion of any animal imported
into the United States does not contain residues
exceeding such tolerance. In establishing such
tolerance, the Secretary shall rely on data
sufficient to demonstrate that a proposed
tolerance is safe based on similar food safety
criteria used by the Secretary to establish
tolerances for applications for new animal drugs
filed under subsection (b)(1). The Secretary may
consider and rely on data submitted by the drug
manufacturer, including data submitted to
appropriate regulatory authorities in any country
where the new animal drug is lawfully used or
data available from a relevant international
organization, to the extent such data are not
inconsistent with the criteria used by the
Secretary to establish a tolerance for
applications for new animal drugs filed under
subsection (b)(1). For purposes of this
paragraph, 'relevant international organization'
means the Codex Alimenterius Commission or other
international organization deemed appropriate by
the Secretary. The Secretary may, under
procedures specified by regulation, revoke a
tolerance established under this new paragraph if
information demonstrates that the use of the new
animal drug under actual use conditions results
in food being imported into the United States
with residues exceeding the tolerance or if
scientific evidence shows the tolerance to be
unsafe.'
19Import TolerancesCongressional Intent
- 3 Members and 1 Senator mentioned import
tolerances in floor remarks during passage - 09/24/96 House and Senate Floor
- Finally, the bill authorizes FDA to establish
import tolerances for new animal drugs not
approved in the U.S. (Mr. Bilirakis)
20Import TolerancesCongressional Intent
- We are pleased that this legislation
incorporates FDA proposals included in the Vice
President's reinventing Government
initiatives,..., and another that will authorize
FDA to establish import tolerances for animal
drugs not approved for use in the United States. - (Mr. Manton)
21Import TolerancesCongressional Intent
- "In addition, the bill implements two items from
the National Performance Review. It would allow
FDA to set tolerances for drugs used on farm
animals whose meat ultimately is imported into
the United States. (Mr. Deutsch)
22Import TolerancesCongressional Intent
- the billpermits FDA to set import tolerances
for drugs used in other countries (Senator
Lugar)
23Import TolerancesCongressional Intent
- 09/24/96 House Commerce Committee issued its
report on ADAA (Report 104-823) - It contained two references to import tolerances
24Import TolerancesCongressional Intent
- A letter from June E. O'Neill, Director of the
Congressional Budget Office to Chairman Tom
Bliley. Comments regarding import tolerances
include - "...The bill would direct the Secretary of Health
and Human Services to establish tolerance levels
for residues of veterinary drugs in imported
animal products intended for human consumption.
... Tolerance Standards. Section 4 of the bill
would require that the residues from animal drugs
in edible animals imported into the United States
meet tolerance standards to be set by the
Secretary. These animal products could not be
deemed unsafe unless their residue levels
exceeded the specified tolerance levels. Under
current law, the United States Department of
Agriculture monitors residues in imported animal
food products, sometimes in consultation with the
Food and Drug Administration (FDA). However,
this section would place a new formal requirement
on the importation of edible animals. Based on
information from FDA staff, CBO expects that the
tolerance standards set by the Secretary would
not differ significantly from current practice.
Thus, this provision would not have significant
costs for the federal government or the private
sector." (Page 11)
25Import TolerancesCongressional Intent
- Section-by-section analysis of the legislation
-
- Section 4 amends section 512(a) to permit FDA to
establish a tolerance for residues of an animal
drug in human foods, when the drug is not
approved for use in the United States but
imported food products of animal origin may
contain residues of that drug. There are
appropriate instances in which food producing
animals raised in other countries are treated
with animal drugs that are not approved in the
United States. For example, the disease or
condition treated by the drug does not occur in
the United States. There have been concerns
about residues of such drugs in food products
derived from these animals, imported into the
United States. -
26Import TolerancesCongressional Intent
- Section-by-Section (continued)
- This provision authorizes FDA to establish a
safe tolerance using criteria similar to those
that it would apply in reviewing the human food
safety aspects of an animal drug for which
approval is sought in the United States. FDA may
rely on data generated by the drug manufacturer
or on data from a relevant international
organization such as the Codex Alimentarius
Commission. This is a step in the right
direction of international harmonization of
regulatory requirements. -
- If an international standard on which FDA relied
changes or new information (from either
experience or scientific data) shows the
tolerance is no longer safe, FDA may change or
revoke the tolerance. In addition, section 4
provides that the tolerance may be revoked if
information shows use of the animal drug under
actual use conditions results in food being
imported into the United States with residues
exceeding the tolerance (Page 16 17)
27ANPR Import Tolerances
- 08/10/01 FDA published an Advance Notice of
Proposed Rulemaking to solicit comments on
establishing drug residue tolerances (import
tolerances) for imported food products of animal
origin for drugs approved in other countries, but
not approved in the U.S.